26
The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved. Amyris Fullbright Course - USP

Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial

condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking

statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should

be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

AmyrisFullbright Course - USP

Page 2: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial

condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking

statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should

be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

Legal Disclaimer

The forward-looking statements included in the presentation may constitute "forward-looking

statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These

statements address the financial condition, results of operations, business and initiatives of the

company in 2008 and beyond and are subject to certain risks and uncertainties that could

cause actual results to differ materially from such forward-looking statements.

The Company undertakes no obligation to update or revise any forward-looking statements to

reflect events or circumstances that may arise after the date of this presentation. Nothing said

today is, or should be relied on as, a promise or representation as to the future performance of

the Company.

The information presented today is confidential and proprietary to the Company and is being

submitted for the recipients’ confidential use with the express understanding that, without the

prior express written permission of the Company, such persons will not discuss the information

presented today with any third parties.

This presentation should not be construed as a general solicitation.

Page 3: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial

condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking

statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should

be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

Overview

► Amyris is an integrated renewable products company producing advanced

renewable fuels and chemicals:

– Proprietary technology already delivered first commercial-scale success

– Use existing sugar/ethanol mills for large volume production

– Commercial scale renewable products in April 2011

► Founded in 2003 on principle of social responsibility: use our know-how to

address biggest health and environmental challenges

► World’s leading investors: Kleiner Perkins, Khosla ventures, TPG

Page 4: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial

condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking

statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should

be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

PMK MPDMK idi ispAHMGSatoB tHMGR ADS

H3C SCoA

O

H

H

OPPOH

OHCH 3

HO 2COPP

OH

H3C SCoA

O

Synthetic BiologyReprogramming microbes to meet specific needs

Page 5: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

Enabling a bio-based economy

Bio-derived products

+

Jet fuel

2020 est: 124 billion gallons

> 50,000

isoprenoidcompounds

+

Amyris engineered yeast in fermentation

Oil

Traditional oil source

Amyris genetically

engineered yeast

Anti-malaria drug non-profit: treat over 200 million people annually

Diesel

2020 est: 450 billion gallons = Petroleum products

+

Cane millSugar cane

=

Refinery

chemicals: e.g. synthetic rubbers, lubricants

Wide range of products

Page 6: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

Application of Synthetic BiologyThe Challenge: Supplying Artemisinin Anti-Malarials

50X increase in production

10X decrease in price,

Consistent, reliable supply

Treating malaria would require:

300 to 500 million treatments per year

Artemisinin treatments needed:

225 to 400 tons of artemisinin per year

This would require:

6,000,000 tons of plant material

Malaria causes:

1 to 3 million deaths per year

Total Chemical

Synthesis

Page 7: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

HO

H

H

O

H

H

OO

H

H

O

HI

H

O

H

H

O

HI

H+

Si((SiMe)3)3

O

O

H

H

O

H

O

H

H

O

H

O

+ +

+

O

H

H

O

H

SS

O

H

H

O

H

SS

+

OMeH

H

O

HO

SS

H

OMeH

H

O

O

SS

H

OMeH

H

O

O

SSH

H3C

OMeH

H

O

O

O H

H3C

O

O

O

OO

H3C

CH3

H

CH3

H

H

Artemisinin

H

ArtemisininTotal Chemical

Synthesis

Supplying ArtemisininChemical Synthesis - Too Expensive and Low-Yields

Page 8: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

HO

O

H

H

H

HO

H

H

O

H

H

OO

H

H

O

HI

H

O

H

H

O

HI

H+

Si((SiMe)3)3

O

O

H

H

O

H

O

H

H

O

H

O

+ +

+

O

H

H

O

H

SS

O

H

H

O

H

SS

+

OMeH

H

O

HO

SS

H

OMeH

H

O

O

SS

H

OMeH

H

O

O

SSH

H3CO

O

O

OO

H3C

CH3

H

CH3

H

H

Artemisinin

H

Move forward to a semi-

synthesis

OMeH

H

O

O

O H

H3C

Artemisinin

Supplying ArtemisininChemical Synthesis - Too Expensive and Low-Yields

Page 9: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

Proven technology – Artemisinin

• Successfully engineered microbe to provide a reliable and affordable supply of artemisinin - key ingredient in malaria treatment

– Entered into development with sanofi-aventis in Jan 2008; successfully transferred strain and processes in mid-2008

– Increased yield 10-fold in 2007 (6-fold since Jan 2008), exceeding sanofi-aventis’ target yield by 25%

• With minor changes to artemisinin microbe, we can access numerous other compounds

• Non-profit project that defined company culture and solidified our commitment to make a difference with our technology

Artemisinin from Amyris Lab

Page 10: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

PMK MPDMK idi ispAHMGSatoB HMGR

Artemisinic

Acid

ADS p450

TerpeneSynthase Hydroxyase Units

CPR

H3C SCoA

O

Acetyl-CoA

ArtemisininArtemisininArtemisininArtemisinin

OPPOH

OHCH 3

HO 2C

OPP

H

H

H

H

O

HO

Mevalonate pathway

PMK MPDMKHMGSatoB HMGR

H3C SCoA

O

Acetyl-

CoA

Jet/GasolineJet/GasolineJet/GasolineJet/Gasoline

OPPOH

OHCH 3

HO2C

Mevalonate pathway

PMK MPDMK idi ispAHMGSatoB HMGR FS

TerpeneSynthase

H3C SCoA

O

Acetyl-CoA

DieselDieselDieselDiesel

OPPOH

OHCH3

HO 2COPP

Mevalonate pathway

MevalonateAmorphadiene

A platform technology for production of multiple products

idi XXX YYY Jet/Gasoline Precursors

Diesel Precursors

Page 11: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

Each of these issues are managed, but at a

cost, requiring changes in:

Refineries Vehicles

Pumps Pipelines

Rail Capacity Trucking Capacity

Ethanol FAME Biodiesel

1st generation biofuelsA fantastic start, but not without compromise

Material Compatibility Problems

High Vapor Pressure

High Water Solubility

Low Energy Density

Poor Oxidation Stability

High Cloud/Freezing Point

Poor Pipeline Transportability

Page 12: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

Engineered Biofuels:A step-change in the industry

Molecules with

good fuel properties

Molecules that

work with today’s

infrastructure

RefiningSynthetic biology

What

biologycan

readilymake

What

biologyis

able tomake

Page 13: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

Amyris breakthrough technology

Amyris engineered microbes can convert sugar to hydrocarbons

Phase-contrast

micrograph of Amyris

engineered microbes

producing precursor to

Amyris Renewable Diesel

Page 14: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

Amyris fermentation-derived hydrocarbons lead to reduced processing costs

Settled Biomass

Fermentation Broth

Amyris diesel

Emulsified Diesel (separates upon low-g centrifugation)

Page 15: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

Amyris No CompromiseTM fuels

• Can be produced using various sugar-containing feedstocks

• Hydrocarbons (not alcohols or esters)

– Can be used in existing engines with

no performance trade-offs

– Can be blended at up to 50%

– Can be delivered using existing

distribution infrastructure

• Superior environmental profile

– 80%+ lower greenhouse gas emissions

than petroleum

– No sulfur

– Lower particulates and NOx

• Price competitive with petroleum

• Received US EPA certification

• Can be produced using various sugar-containing feedstocks

• Hydrocarbons (not alcohols or esters)

– Can be used in existing engines with

no performance trade-offs

– Can be blended at up to 50%

– Can be delivered using existing

distribution infrastructure

• Superior environmental profile

– 80%+ lower greenhouse gas emissions

than petroleum

– No sulfur

– Lower particulates and NOx

• Price competitive with petroleum

• Received US EPA certification Amyris diesel fuel (clear) in front; petroleum diesel (yellow) in the back

Page 16: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

Purification

• Inexpensive process to

remove low-level impurities

Cane processing

• No change to the most

capital intensive part of

ethanol production

Dehydration

• This stage not required

because hydrocarbons

separate easily from water

Electricity Generation• Can generate extra electricity

from the steam normally used

to drive the distillation

Cane Processing

Fermentation

• Engineered yeast

• Modified fermenters to

satisfy oxygen delivery

Finishing

• Chemical step converts

precursor into final product

Chemical Finishing

Cane Processing

FermentationRecovery

(Centrifuges)Purification Dehydration

Amyris’ sugarcane to diesel production process

Page 17: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

Amyris Diesel:Validated by external labs as a “best-in-class” product

AMYRIS BIOTECHNOLOGIES CONFIDENTIAL & PROPRIETARTY NOT FOR

DISTRIBUTION

- Amyris diesel will be used in blends with conventional fuels; values shown for Amyris diesel is for our biomass derived blending component- SME = Soy Methyl Esters

0 20 40 60

Amyris

SME

#2-D

Cetane Number

-75 -50 -25 0

Amyris

SME

#2-D

Cloud Pointdegrees Celsius

+1

< -50

-9 to -30

0 50 100 150

Amyris

SME

#2-D

Energy Density1000 BTU/gal

58.6

47

40-55

132

118

115-142

Page 18: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

Amyris Diesel: Regulated EmissionsSignificant reductions in NOx, PM, CO, and HC

-1.9%-4.7%

-12%

-0.11%

+2.0%

-15%

-10%

-5%

0%

5%

10%

15%

5% 20% 50% 20% 20%

Ch

an

ge

vs.

Ba

se

lin

e

NOx

-1.5%

-5.7%

-3.1%

-10.1%-12%

-10%

-8%

-6%

-4%

-2%

0%

5% 20% 50% 20% 20%

Ch

an

ge

vs.

Ba

se

lin

e

PM

-6.6%

-3.6%

-12%

-20% -21%-25%

-20%

-15%

-10%

-5%

0%

Ch

an

ge

vs.

Ba

se

lin

e

HC

-2.1%

-7.1%

-15% -15%

-11%

-15%

-12%

-9%

-6%

-3%

0%

Ch

an

ge

vs.

Ba

se

lin

e

CO

% FAME in Fed. Diesel*

% Amyris in Federal

Diesel*

% Amyris

in CARB Diesel*

* Detroit Diesel Series 60 engine (5 gram NOx) no EGR , tested at SwRI May 2008 ** Source: EPA (http://www.epa.gov/otaq/models/analysis`/biodsl/p02001.pdf)

% FAME in Fed. Diesel*

% Amyris in Federal

Diesel*

% Amyris

in CARB Diesel*

-0.26%

Page 19: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

Business model

TECHNOLOGY

• Pioneering technology platform capable of making more than 50,000 molecules

• New strain of yeast turns sugar into hydrocarbons

MANUFACTURING

• Access to lowest cost feedstock (first sugarcane, then cellulosic)

• Lowest carbon footprint

• Owned and 3rd party production assets

PRODUCTS

• No Compromise® fuels

• Family of renewable chemicals

• Anti-malarial ingredient (non-profit initiative)

Integrated renewable products company

Page 20: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

Energy Security through supply diversification…Sugarcane potential is not nearly as concentrated as oil.

Source: British Sugar c/o UNICA

Page 21: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

Amyris today

Emeryville, California

• ABI headquarters

• labs, pilot plant

Campinas, Brazil

• Amyris Brasil• labs, pilot plant &

demo facility

• production in 2011

Chicago, Illinois• Amyris Fuels LLC

• Renewable fuels marketing and distribution

Europe• Anti-malarial partnership

with sanofi-aventis

Alabama

• sugar cane nursery project

… combining great science and innovative business to create a more sustainable world

Page 22: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

Amyris will participate in various aspects along the biofuels value chain

Amyris GreenLaneTM

Partner with large scale

manufacturer with access to

low cost feedstocks

• Take product from plant

gate to wholesaler

• Logistics contracts to

facilitate high volume

distribution

• Sell to fastest growing

retail segment

• Access to end

customers (commercial

accounts)

Commercial Customers

ManufacturingTransportation & Logistics

Terminal &blend racks

Retail Customers

TechnologyFeedstock

Participation in value chain

Amyris participation

Page 23: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

Convert Brazil ethanol mills to produce

Amyris renewable products• Engineering of

commercial plant has been finalized and EPCM CH2Hill has

been engaged

Commercialize first

product out of demo facility

First large scale production of Amyris

renewable products

Continue mill

conversion and expansion

First commercial production by third

party mills

20092009 20102010 20112011 20122012

Brazil R&D center inaugurated in

Campinas

Brazil and US Pilot

plant operational

Brazil Demo Facility

opened

Secure production in

Brazil

• Owned/controlled

• Third parties

Pathway to commercialization

Page 24: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

Amyris corporate strategy

Our planned 5 year journey

2008 2009 2010 2011 2012

Increasing value

Pilot plant in US

R & D to improve yield

Launch Amyris Renewable DieselEstablished strategic

alliance with

SantelisaVale – access

to 2M tons of cane

Began ethanol sourcing/supply

business in US – generated revenue

Fuel testing and certification

Launch Amyris Renewable Chemicals

Launch Amyris Renewable Jet Fuels

Pilot plant in Brazil

R & D to improve yield

Page 25: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

Management: industry leading team

Board Members(external)

Founders

Jay Keasling (Chair, SAB; Technical Advisor)

Professor at UC Berkeley

Jack Newman (SVP Research)

Kinkead Reiling (SVP Corporate

Development)

Neil Renninger (CTO)

Select OfficersJohn Melo (CEO)Former President of US Fuels, BP

Paul Adams (SVP, Commercial)

Former VP of Supply & Trading, BP

Jeryl Hilleman (CFO)Former CFO, Symyx Technologies

Jeff Lievense (SVP, Process Development and Manufacturing)Former VP Technology & Process

Development, Tate and Lyle

Joel Cherry (SVP, Research Programs

and Operations)Former Senior Director, Novozymes

John Doerr

Kleiner Perkins Caufield & Byers

Samir Kaul

Khosla Ventures

Geoff Duyk TPG Biotechnology

Ralph Alexander

Riverstone LLC

Fernando Reinach

Votorantim

Management

Roel Collier, former Boston Consulting Group and Clean Energy Brazil

Jose Eduardo Patelli, former Votorantim

Biocombustíveis Ltda

Board and Advisors

Rui Ferraz, Crystalsev

Paul Adams, Jeff Lievense, Amyris

Roberto Rodrigues, ex-minister of Agriculture

Fernando Reinach, Votorantim

Page 26: Amyris.ppt [Modo de Compatibilidade] - IEA USPThe forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private

The forward-looking statements included in the presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements address the financial condition, results of operations, business and initiatives of the company in 2008 and beyond and are subject to certain risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this presentation. Nothing said today is, or should be relied on as, a promise or representation as to the future performance of the Company. This presentation should not be construed as a general solicitation. @ 2008 Amyris Technologies. All rights reserved.

Select awards

2005 2006 2007 2008

“Energy Innovator” – US DOE

Fortune’s “11 Great Green Ideas”

Popular Mechanics Breakthrough Awards 2008

Scientific American –Business Leader of the Year

AlwaysOnGoingGreen100 Top Private Companies

AlwaysOn100 Top Private Companies

Co-founder Neil Renninger, Ph. D. named as top 35 young innovators

Red Herring 100 –Top 100 most innovative privately held technology co’s.

World Technology Award for Biotechnology by World Technology Network

World Economic Forum – Technology Pioneer